Clinical trials
Multiple Myleoma clinical trials
Below are recruiting multiple myleoma clinical trials, each written for real people, not researchers. We’re tracking 2 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05645107RecruitingPhase 3
XEMBIFY plus usual care to prevent infections
This Phase 3 study tests whether XEMBIFY (an immune protein therapy) plus standard medical treatment can better prevent serious or repeated infections. It is for people with certain cancers of blood/immune systems who are already having trouble with infections.
Huntington Park, CaliforniaAges 18 years+ - NCT06952075RecruitingPhase 2
GR1803 for Multiple Myeloma with Soft Tissue Spread
This trial tests an experimental drug called GR1803 for people with multiple myeloma that has spread to soft tissue areas outside the bone. The goal is to see if it can help shrink these tumors.
Tianjin, Tianjin MunicipalityAges 18 years+
Hear when a new Multiple Myleoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for multiple myleoma?
- Yes. Clin2 currently lists 2 recruiting multiple myleoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a multiple myleoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a multiple myleoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.